ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976